ATE496913T1 - Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen - Google Patents
Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungenInfo
- Publication number
- ATE496913T1 ATE496913T1 AT06708235T AT06708235T ATE496913T1 AT E496913 T1 ATE496913 T1 AT E496913T1 AT 06708235 T AT06708235 T AT 06708235T AT 06708235 T AT06708235 T AT 06708235T AT E496913 T1 ATE496913 T1 AT E496913T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- new
- long
- respiratory diseases
- acting betamimetics
- Prior art date
Links
- 239000000808 adrenergic beta-agonist Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005007654A DE102005007654A1 (de) | 2005-02-19 | 2005-02-19 | Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen |
| PCT/EP2006/050898 WO2006087315A1 (de) | 2005-02-19 | 2006-02-13 | Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE496913T1 true ATE496913T1 (de) | 2011-02-15 |
Family
ID=36607505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06708235T ATE496913T1 (de) | 2005-02-19 | 2006-02-13 | Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7423036B2 (enExample) |
| EP (1) | EP1853596B1 (enExample) |
| JP (1) | JP5140434B2 (enExample) |
| AR (1) | AR053135A1 (enExample) |
| AT (1) | ATE496913T1 (enExample) |
| CA (1) | CA2598355A1 (enExample) |
| DE (2) | DE102005007654A1 (enExample) |
| ES (1) | ES2357620T3 (enExample) |
| TW (1) | TW200640911A (enExample) |
| WO (1) | WO2006087315A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US20050272726A1 (en) * | 2004-04-22 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Novel medicaments for the treatment of respiratory diseases |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| BRPI0614410A2 (pt) | 2005-08-15 | 2011-03-29 | Boehringer Ingelheim Int | processo para preparação de betamiméticos |
| EP2057152A1 (de) * | 2006-08-07 | 2009-05-13 | Boehringer Ingelheim International GmbH | Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| CA2660186A1 (en) * | 2006-08-07 | 2008-02-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of respiratory diseases |
| GB0913342D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | Compounds - 801 |
| WO2011048409A1 (en) | 2009-10-20 | 2011-04-28 | Astrazeneca Ab | Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| GB201009801D0 (en) | 2010-06-11 | 2010-07-21 | Astrazeneca Ab | Compounds 950 |
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2609645A1 (de) | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
| US4460581A (en) | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| SK15382002A3 (sk) | 2000-04-27 | 2003-03-04 | Boehringer Ingelheim Pharma Kg | Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie |
| DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
| PE20050130A1 (es) * | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| BRPI0409198A (pt) * | 2003-04-04 | 2006-05-02 | Novartis Ag | derivados quinolin-2-ona para o tratamento de doenças de vias aéreas |
| EP1651221B1 (en) * | 2003-07-28 | 2009-01-14 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| EP1654001A2 (en) * | 2003-08-05 | 2006-05-10 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and a betamimetic |
| US7405232B2 (en) | 2004-02-14 | 2008-07-29 | Boehringer Ingelheim International Gmbh | Long acting beta-2 agonists and their use as medicaments |
| DE502005010170D1 (de) * | 2004-02-14 | 2010-10-14 | Boehringer Ingelheim Pharma | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel |
| DE102004024453A1 (de) * | 2004-05-14 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen |
| DE102004024454A1 (de) | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| US7745621B2 (en) | 2004-05-14 | 2010-06-29 | Boehringer Ingelheim International Gmbh | Long acting bronchodilators for the treatment of respiratory diseases |
-
2005
- 2005-02-19 DE DE102005007654A patent/DE102005007654A1/de not_active Withdrawn
-
2006
- 2006-02-13 CA CA002598355A patent/CA2598355A1/en not_active Abandoned
- 2006-02-13 AT AT06708235T patent/ATE496913T1/de active
- 2006-02-13 DE DE502006008804T patent/DE502006008804D1/de not_active Expired - Lifetime
- 2006-02-13 JP JP2007555588A patent/JP5140434B2/ja not_active Expired - Fee Related
- 2006-02-13 EP EP06708235A patent/EP1853596B1/de not_active Expired - Lifetime
- 2006-02-13 ES ES06708235T patent/ES2357620T3/es not_active Expired - Lifetime
- 2006-02-13 WO PCT/EP2006/050898 patent/WO2006087315A1/de not_active Ceased
- 2006-02-15 US US11/355,065 patent/US7423036B2/en not_active Expired - Lifetime
- 2006-02-17 AR ARP060100567A patent/AR053135A1/es not_active Application Discontinuation
- 2006-02-17 TW TW095105331A patent/TW200640911A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008530176A (ja) | 2008-08-07 |
| CA2598355A1 (en) | 2006-08-24 |
| ES2357620T3 (es) | 2011-04-28 |
| TW200640911A (en) | 2006-12-01 |
| EP1853596B1 (de) | 2011-01-26 |
| WO2006087315A1 (de) | 2006-08-24 |
| JP5140434B2 (ja) | 2013-02-06 |
| EP1853596A1 (de) | 2007-11-14 |
| DE102005007654A1 (de) | 2006-08-24 |
| DE502006008804D1 (de) | 2011-03-10 |
| US20060189607A1 (en) | 2006-08-24 |
| US7423036B2 (en) | 2008-09-09 |
| AR053135A1 (es) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
| ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| DE602005017636D1 (de) | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE447551T1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DK1817282T3 (da) | Til behandling af respiratoriske sygdomme egnede phenoxy derivater | |
| DE602006019468D1 (de) | Diarylharnstoffe zur behandlung von pulmonaler hypertonie | |
| ATE510536T1 (de) | Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen | |
| ATE482709T1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| EP1965827A4 (en) | TREATMENT OF CONDITIONS RELATED TO DEMYELINATION | |
| ATE537178T1 (de) | Neue klasse von spiro-piperidinen zur behandlung neurodegenerativer krankheiten | |
| ATE496913T1 (de) | Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen | |
| DK1962869T3 (da) | Behandling af luftvejssygdomme | |
| ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. |